T2 Biosystems (TTOO)
(Delayed Data from NSDQ)
$3.93 USD
-0.07 (-1.75%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $3.92 -0.01 (-0.25%) 5:56 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
T2 Biosystems, Inc. [TTOO]
Reports for Purchase
Showing records 21 - 28 ( 28 total )
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
T2Bacteria Receives FDA Clearance; 100% Growth Forecast for 2019 and 2020; Reiterate Buy and Raising Price Target to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
U.S. and EU Studies of T2Dx Diagnostics Published; Reiterate Buy and Raising Price Target to $8.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
2017 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
T2Candida Beats Blood Culture in Detection and Monitoring of Candidemia; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Potential Approval of T2Bacteria in the Current Quarter; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
3Q17 Financial Results In Line; T2Bacteria Panel Approval Pending; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: T2 Biosystems, Inc.
Industry: Medical - Instruments
Detecting Sepsis in Whole Blood Within Hours; Initiating at Buy and $8 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R